EBV drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (4)
Papers in which this entity is mentioned.
- Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
- The Immune Landscape of Cancer. (2018)
- Profiling tissue-resident T cell repertoires by RNA sequencing. (2015)
- Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ebv | drug | 9 | 12 |
| ebv-immortalized cell lines | drug | — | — |
| ebv-transformed lymphoblastoid cell lines | drug | — | — |